2016 Conference
    Home
    • 2016 Conference
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Exhibition
    • 2015 Archive
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Exhibition
    • 2014 Archive
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Exhibition
    • 2013 Archive
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Exhibition
    • 2012 Archive
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Accommodation
      • Exhibition
      • Photos
    • 2011 Archive
      • Programme
      • Presentations A-Z
      • Posters A-Z
      • Delegate list
      • Venue
      • Exhibition
      • Photos
    • Archive 2005 - 2010
        About us
        2013 Archive Presentation
        AbstractBiography
        Smoking cessation medications and pregnant smokers

         
         
         
        Update RequiredTo play the media you will need to either update your browser to a recent version or update your Flash plugin.

        Click here to download the presentation (Powerpoint or viewer needed)
        Author(s)

        Cheryl Ann Oncken

        Presenter(s)

        Dr Cheryl Oncken  Professor of Medicine and Obstetrics and Gynecology, University of Connecticut School of Medicine & Director, Clinical Research Center, University of Connecticut Health Center, USA

        Abstract

        Although medications are recommended for most smokers, there is a paucity of data in pregnant women.  Given the significant health risks of maternal smoking, and the potential of pharmacotherapy to increase quit rates, a need exists to examine the safety and efficacy of pharmacotherapy for smoking cessation during pregnancy.  

        Dr. Oncken's presentation will focus on medications for smoking cessation during pregnancy. She will review the health risks of smoking during pregnancy, and what is known regarding the benefit/risk profile of various pharmacotherapies (gum, patch, bupropion, varenicline) for smoking cessation during pregnancy.  She will also review studies that have examined the efficacy or effectiveness of nicotine replacement therapy for smoking cessation during pregnancy. Future directions for research regarding medications for smoking cessation during pregnancy will also be discussed.


        Source of funding: NIH

        Declaration of interest: Dr. Oncken has received  free nicotine and placebo inhalers from Pfizer pharmaceuticals.

         
        Abstract
        Join our mailing list